The Combination Products Summit 2026 in Providence, RI, brings together experts from pharma, medtech, and regulatory fields to address evolving standards for the development, manufacturing, and safety of drug-device combination products. With increasing scrutiny from regulators in North America and Europe, the program focuses on quality, compliance, and insights into trends in combination product development for drugs, biologics and medical devices.
Ypsomed’s Karolína Šnajdarová will share how early collaboration, platform technologies, and regulatory expertise can reduce complexity and support faster, more reliable pathways to clinic and market.
Make sure to attend Karolína’s session for practical insights on accelerating clinical development for combination products.
Our speaker at the conference
Karolína Šnajdarová
Regulatory Affairs Manager
- Topic: Strategies for streamlining clinical development programs for drug-device combination products
- Date & time: 28 May, 2.00 pm
